Feed Preview

Fast Growing

Alzheimer's Disease: Neuroimaging

Alzheimer's Disease: Neuroimaging diagram by

Alzheimer's disease (AD) is a chronic neurodegenerative disease. Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Top 20 most recent papers
Annals of Neurology

Imaging Biomarkers of Alzheimer's Disease in Multiple Sclerosis

Annals of NeurologyJanuary 24, 2020
Burcu ZeydanKejal Kantarci
4
Scientific Reports

Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons

Scientific ReportsJanuary 19, 2020
Tugce Munise SatirPetra Bergström
2
1
1
bioRxiv

Multimodal magnetic resonance imaging predicts regional amyloid-β burden in the brain

bioRxivJanuary 18, 2020
Anusha Alathur RangarajanHoward Aizenstein
3
NeuroImage. Clinical

Hippocampal plasticity underpins long-term cognitive gains from resistance exercise in MCI

NeuroImage. ClinicalJanuary 25, 2020
Kathryn M BroadhouseMichael J Valenzuela
Neuropsychologia

Forgetting in Alzheimer's disease: Is it fast? Is it affected by repeated retrieval?

NeuropsychologiaJanuary 25, 2020
Andreea StamateSergio Della Sala
Journal of the International Neuropsychological Society : JINS

Differential Item Functioning of the Everyday Cognition (ECog) Scales in Relation to Racial/Ethnic Groups

Journal of the International Neuropsychological Society : JINSJanuary 25, 2020
Teresa FilshteinSarah Farias
Alzheimer's Research & Therapy

Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease

Alzheimer's Research & TherapyJanuary 24, 2020
Kenta YoshidaAngelica Quartino
1
Bioinformatics

Morbigenous brain region and gene detection with a genetically evolved random neural network cluster approach in late mild cognitive impairment

BioinformaticsJanuary 24, 2020
Xia-An BiAlzheimer’s Disease Neuroimaging Initiative
5
International Psychogeriatrics

18 F]FDDNP PET binding predicts change in executive function in a pilot clinical trial of geriatric depression

International PsychogeriatricsJanuary 24, 2020
Beatrix Krause-SorioHelen Lavretsky
Neurology

Differential neurocognitive network perturbation in amnestic and aphasic Alzheimer disease

NeurologyJanuary 24, 2020
Adam MartersteckEmily Rogalski
Journal of Alzheimer's Disease : JAD

Pine Bark Polyphenolic Extract Attenuates Amyloid-β and Tau Misfolding in a Model System of Alzheimer's Disease Neuropathology

Journal of Alzheimer's Disease : JADJanuary 21, 2020
Kenjiro OnoGiulio Maria Pasinetti
1
European Radiology

MRI in patients with implanted active devices: how to combine safety and image quality using a limited transmission field?

European RadiologyJanuary 25, 2020
Laura LundenOlav Jansen
American Journal of Nuclear Medicine and Molecular Imaging

Reduction in amyloid β deposition on 18 F-florbetapir positron emission tomography with correction of cerebral hypoperfusion after endarterectomy for carotid stenosis

American Journal of Nuclear Medicine and Molecular ImagingJanuary 25, 2020
Kuniaki OgasawaraYoshitaka Kubo
Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in Medicine

A Novel Deep Learning Approach with a 3D Convolutional Ladder Network for Differential Diagnosis of Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease

Magnetic Resonance in Medical Sciences : MRMS : an Official Journal of Japan Society of Magnetic Resonance in MedicineJanuary 24, 2020
Ryusuke IrieShigeki Aoki
Journal of Clinical and Experimental Neuropsychology

Visuospatial performance in patients with statistically-defined mild cognitive impairment

Journal of Clinical and Experimental NeuropsychologyJanuary 25, 2020
Victor WassermanDavid J Libon
bioRxiv

Completion and augmentation of connectomic datasets in dementia and Alzheimer's Disease using Virtual Patient Cohorts

bioRxivJanuary 18, 2020
Djouya Mohammad ArbabyazdViktor Jirsa
5
Expert Opinion on Drug Safety

An update on the utility and safety of cholinesterase inhibitors for the treatment of Alzheimer's disease

Expert Opinion on Drug SafetyJanuary 25, 2020
Andrea HaakeGeorge T Grossberg
Frontiers in Cellular Neuroscience

Activation of Mitochondrial Unfolded Protein Response in SHSY5Y Expressing APP Cells and APP/PS1 Mice

Frontiers in Cellular NeuroscienceJanuary 24, 2020
Yang ShenJianzhong Bi
8
Brain Plasticity

Brain Glucose Metabolism, Cognition, and Cardiorespiratory Fitness Following Exercise Training in Adults at Risk for Alzheimer's Disease

Brain PlasticityJanuary 24, 2020
Julian M GaitánOzioma C Okonkwo
Journal of the Neurological Sciences

Correlation between regional brain volume and olfactory function in very mild amnestic patients

Journal of the Neurological SciencesJanuary 24, 2020
Tetsuo KashibayashiHiroaki Kazui
1

See more papers from this feed

Related Feeds

AFM in situ DNA

AFM in situ DNA describes in situ analysis (or study) of DNA using atomic force microscopy. Discover the latest research on AFM in situ DNA here.

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

© 2020 Meta ULC. All rights reserved
/feed-previews/alzheimers-disease-neuroimaging/a5242adb-290c-4f90-bd45-b0d1bbfc9166